Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors

Journal of Infectious Diseases

Volumn 175, Issue 3, 1997, Pages 697-700

  Bergelsen, Jeffrey M ^a   Modlin, John F ^b   Wieland Alter, Wendy ^b   Cunningham, Jennifer A ^b   Crowell, Richard L ^b   Finberg, Robert W ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COXSACKIE VIRUS B; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; RECEPTOR BINDING; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS TYPING;

EID: 0031017692     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.3.697     Document Type: Article

References (14)

1. Crowell RL, Landau MA. Receptors in the initiation of picornavirus infections. In: Fraenkel-Conrat H, Wagner RR, eds. Comprehensive virology. New York: Plenum Publishing, 1983:1-42.
2. Mapoles JE, Krah DL, Crowell RL. Purification of a HeLa cell receptor protein for group B coxsackieviruses. J Virol 1985;55:560-6.
3. Hsu KHL, Paglini S, Alstein B, Crowell RL. Identification of a second cellular receptor for a coxsackievirus B3 variant, CB3-RD. In: Brinton M, Heinz F, eds. New aspects of positive-strand RNA viruses. Washington, DC: American Society for Microbiology, 1990:271-7.
4. Hsu KHL, Lonberg-Holm K, Alstein B, Crowell RL. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol 1988;62:1647-52.
5. Bergelson JM, Mohanty JG, Crowell RL, St. John NF, Lublin DM, Finberg RW. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol 1995;69:1903-6.
6. Crowell RL, Field AK, Schlief WA, et al. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade. J Virol 1986;57:438-45.
7. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995;69:3873-7.
8. Berlin L, Rorabaugh M, Heldrich F, Roberts K, Doran T, Modlin J. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 1993;168:888-92.
9. Bergelson JM, Chan M, Solomon K, St. John NF, Lin H, Finberg RW. Decay-accelerating factor, a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 1994;91:6245-8.
10. Brubaker JO, Thompson CM, Morrison LA, Knipe DM, Siber GR, Finberg RW. Th1-associated immune responses to β-galactosidase expressed by a replication-defective herpes simplex virus. J Immunol 1996;157: 1598-604.
11. Bergelson JM, St. John N, Kawaguchi S, et al. Infection by echoviruses 1 and 8 depends on the α2 subunit of human VLA-2. J Virol 1993;67: 6847-52.
12. Bergelson JM, Chan BMC, Finberg RW, Hemler ME. The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms. J Clin Invest 1993;92:232-9.
13. Rossmann MG, Arnold E, Erickson JW, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985;317:145-53.
14. Reagan KJ, Goldberg B, Crowell RL. Altered receptor specificity of coxsackie B3 after growth in rhabdomyosarcoma cells. J Virol 1984;49: 635-40.